Quantcast
Last updated on April 19, 2014 at 13:20 EDT

Latest Pulsatile insulin Stories

2014-04-09 23:04:33

Diasome Pharmaceuticals, Inc. Announces Two New Board Members Cleveland, Ohio (PRWEB) April 09, 2014 Diasome Pharmaceuticals, Inc. (http://www.diasome.com) has announced that Frank McCaney, CEO of Corpak MedSystems, Inc., and Thomas McDonald, founder and CEO of McDonald Partners LLC, have joined its board of directors. Mr. McCaney’s career includes serving in senior management positions at Thermo Electron Corporation and Viasys Healthcare, where he played a lead role in spinning Viasys...

2014-03-06 23:04:04

Hepatic Targeted Nanotechnology Focuses On Providing Better Liver Function To Assist In Weight Loss Cleveland, Ohio (PRWEB) March 06, 2014 Diasome Pharmaceuticals, Inc. (http://www.diasome.com) has received notice from its licensor, SDG, Inc., that SDG has received a notice of allowance for its novel weight loss nanotechnology patent application. This patent, entitled “Orally Bioavailable Lipid Constructs,” covers composition of matter claims related to the use of the Company’s...

2014-03-04 23:21:59

A Collaboration Focused on the Continued Development of Diabetes and Obesity Breakthroughs Cleveland, OH (PRWEB) March 04, 2014 Diasome Pharmaceuticals, Inc. (http://www.diasome.com) has announced that it has entered into an exclusive investment advisory engagement with McDonald Partners LLC, (http://www.mcdonald-partners.com) a Cleveland, Ohio company that provides full service brokerage, financial advisory and investment banking services to individual, institutional and corporate...

2012-08-29 06:25:18

KALAMAZOO, Mich., Aug. 29, 2012 /PRNewswire/ -- Researchers at Metabolic Solutions Development Company, LLC (MSDC) have identified a mitochondrial protein complex through which insulin sensitizers achieve their anti-diabetic effects. Findings from this research are being presented August 30 at the Benzon Symposium No. 58 in Copenhagen, Denmark. The newly identified mitochondrial target is being referred to as the mitochondrial Target of Thiazolidinediones, or mTOT((TM)). Key...

2012-06-25 20:57:40

A fungicide used on farm crops can induce insulin resistance, a new tissue-culture study finds, providing another piece of evidence linking environmental pollutants to diabetes. The results will be presented Saturday at The Endocrine Society's 94th Annual Meeting in Houston. "For the first time, we've ascribed a molecular mechanism by which an environmental pollutant can induce insulin resistance, lending credence to the hypothesis that some synthetic chemicals might be contributors to the...

2012-05-07 11:05:51

A Penn research team, led by Mitchell Lazar, MD, PhD, director of the Institute for Diabetes, Obesity, and Metabolism at the Perelman School of Medicine, University of Pennsylvania, reports in Nature Medicine that mice in which an enzyme called histone deacetylase 3 (HDAC3) was deleted had massively fatty livers, but lower blood sugar, and were thus protected from glucose intolerance and insulin resistance, the hallmark of diabetes. Insulin resistance occurs when the body does a poor job...

2012-01-09 17:25:30

New research published in the American Journal of Pathology New research reveals that insulin applied in therapeutic doses selectively stimulates the formation of new elastic fibers in cultures of human aortic smooth muscle cells. These results advance the understanding of the molecular and cellular mechanisms of diabetic vascular disease. The study is published in the February issue of the American Journal of Pathology. "Our results particularly endorse the use of insulin therapy for...

2011-10-29 07:00:00

The research team demonstrated that the major downstream path used by insulin to control the genes is also related to the pathways that control the metabolization of nutrients, as reported by DiabeticLive.com. Orlando, FL (PRWEB) October 29, 2011 Lipid accumulation in the liver almost always accompanies insulin resistance and obesity, both warning signs of Type 2 diabetes. Such lipid accumulation can be deadly, leading to liver failure and hepatitis. However, doctors have been stumped as to...

2011-03-24 20:53:19

Researchers at UT Southwestern Medical Center have discovered a hormone pathway that potentially could lead to new ways of treating type 1 diabetes independent of insulin, long thought to be the sole regulator of carbohydrates in the liver. Results of this new study will be published March 25 in Science. Another hormone, fibroblast growth factor 19 (FGF19), has insulin-like characteristics beyond its role in bile acid synthesis. Unlike insulin, however, FGF19 does not cause excess glucose to...

2011-02-16 16:26:25

Researchers from Mount Sinai School of Medicine have discovered a novel function of brain insulin, indicating that impaired brain insulin action may be the cause of the unrestrained lipolysis that initiates and worsens type 2 diabetes in humans. The research is published this month in the journal Cell Metabolism. Led by Christoph Buettner, MD, Assistant Professor of Medicine in the Division of Endocrinology, Diabetes and Bone Disease at Mount Sinai School of Medicine, the research team first...